Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Evaluation of VZV-specific cell-mediated immunity in adults infected with HIV-1 by using a simple IFN-γ release assay.

Watanabe D, Otani N, Suzuki S, Dohi H, Hirota K, Yonemoto H, Koizumi Y, Otera H, Yajima K, Nishida Y, Uehira T, Shima M, Shirasaka T, Okuno T.

J Med Virol. 2013 Aug;85(8):1313-20. doi: 10.1002/jmv.23611. Epub 2013 May 22.

PMID:
23703688
2.

Varicella-zoster virus-specific cell-mediated immune responses in HIV-infected adults.

De Castro N, Carmagnat M, Kernéis S, Scieux C, Rabian C, Molina JM.

AIDS Res Hum Retroviruses. 2011 Oct;27(10):1089-97. doi: 10.1089/AID.2010.0340. Epub 2011 May 4.

PMID:
21417759
3.

Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.

Hayashida K, Ozaki T, Nishimura N, Gotoh K, Funahashi K, Nakane K, Gomi Y, Manabe S, Ishikawa T, Yamanishi K.

J Immunol Methods. 2015 Nov;426:50-5. doi: 10.1016/j.jim.2015.07.011. Epub 2015 Jul 29.

PMID:
26232696
4.

Varicella-zoster virus-specific cell-mediated immunity in subjects with herpes zoster.

Otani N, Yamanishi K, Sakaguchi Y, Imai Y, Shima M, Okuno T.

J Immunol Methods. 2012 Mar 30;377(1-2):53-5. doi: 10.1016/j.jim.2012.01.003. Epub 2012 Jan 12.

PMID:
22261191
5.

Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy.

Weinberg A, Wiznia AA, LaFleur BJ, Shah S, Levin MJ.

J Infect Dis. 2004 Jul 15;190(2):267-70. Epub 2004 Jun 9.

PMID:
15216460
6.

Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.

Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJ, Caulfield MJ.

J Infect Dis. 2003 Nov 1;188(9):1336-44. Epub 2003 Oct 17.

PMID:
14593591
7.

Interferon-gamma release assay: a simple method for detection of varicella-zoster virus-specific cell-mediated immunity.

Otani N, Baba K, Okuno T.

J Immunol Methods. 2009 Dec 31;351(1-2):71-4. doi: 10.1016/j.jim.2009.09.010. Epub 2009 Oct 8.

PMID:
19818791
8.

Varicella-zoster virus-specific, cell-mediated immunity with interferon-gamma release assay after vaccination of college students with no or intermediate IgG antibody response.

Terada K, Itoh Y, Fujii A, Kitagawa S, Ogita S, Ouchi K.

J Med Virol. 2015 Feb;87(2):350-6. doi: 10.1002/jmv.24031. Epub 2014 Jul 31.

PMID:
25080078
9.

Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial.

Trannoy E, Berger R, Holländer G, Bailleux F, Heimendinger P, Vuillier D, Creusvaux H.

Vaccine. 2000 Feb 25;18(16):1700-6.

PMID:
10689152
10.

Relationship between cell-mediated immunity to Varicella-Zoster virus and aging in subjects from the community-based Shozu Herpes Zoster study.

Shirane R, Tang H, Hayashi K, Okuno Y, Iso H, Asada H, Yamanishi K, Mori Y; SHEZ study group.

J Med Virol. 2017 Feb;89(2):313-317. doi: 10.1002/jmv.24629. Epub 2016 Jul 29.

PMID:
27420414
11.

Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.

Berger R, Luescher D, Just M.

Postgrad Med J. 1985;61 Suppl 4:143-5.

PMID:
3014472
12.

Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.

Levin MJ, Schmader KE, Pang L, Williams-Diaz A, Zerbe G, Canniff J, Johnson MJ, Caldas Y, Cho A, Lang N, Su SC, Parrino J, Popmihajlov Z, Weinberg A.

J Infect Dis. 2016 Jan 1;213(1):14-22. doi: 10.1093/infdis/jiv480. Epub 2015 Oct 9.

PMID:
26452397
13.

Varicella-zoster virus-specific enzyme-linked immunospot assay responses and zoster-associated pain in herpes zoster subjects.

Tyring SK, Stek JE, Smith JG, Xu J, Pagnoni M, Chan IS, Silber JL, Parrino J, Levin MJ.

Clin Vaccine Immunol. 2012 Sep;19(9):1411-5. doi: 10.1128/CVI.00095-12. Epub 2012 Jul 11.

14.

Subsets of T-cells and in vitro cytokine production after measles and varicellae-zoster virus antigen stimulation in allogeneic BMT patients.

Pauksen K, Sjölin J, Linde A, Andersson B, Lenkei R, Oberg G, Ljungman P.

Scand J Infect Dis. 1999;31(1):43-9.

PMID:
10381217
15.

Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay.

Sadaoka K, Okamoto S, Gomi Y, Tanimoto T, Ishikawa T, Yoshikawa T, Asano Y, Yamanishi K, Mori Y.

J Infect Dis. 2008 Nov 1;198(9):1327-33. doi: 10.1086/592219.

PMID:
18774884
16.

Safety and immunogenicity of a live attenuated varicella vaccine in VZV-seropositive HIV-infected adults.

Weinberg A, Levin MJ, Macgregor RR.

Hum Vaccin. 2010 Apr;6(4):318-21. Epub 2010 Apr 15.

PMID:
20372089
17.

Immune response of elderly individuals to a live attenuated varicella vaccine.

Levin MJ, Murray M, Rotbart HA, Zerbe GO, White CJ, Hayward AR.

J Infect Dis. 1992 Aug;166(2):253-9.

PMID:
1321859
18.

A dose-response study of a live attenuated varicella-zoster virus (Oka strain) vaccine administered to adults 55 years of age and older.

Berger R, Trannoy E, Holländer G, Bailleux F, Rudin C, Creusvaux H.

J Infect Dis. 1998 Nov;178 Suppl 1:S99-103.

PMID:
9852985
19.

Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.

van Besouw NM, Verjans GM, Zuijderwijk JM, Litjens NH, Osterhaus AD, Weimar W.

J Med Virol. 2012 Dec;84(12):2018-25. doi: 10.1002/jmv.23427.

PMID:
23080511
20.

Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity*.

L'Huillier AG, Ferry T, Courvoisier DS, Aebi C, Cheseaux JJ, Kind C, Rudin C, Nadal D, Hirschel B, Sottas C, Siegrist CA, Posfay-Barbe KM; Pediatric Infectious Diseases Group of Switzerland; Group of Switzerland (PIGS); Swiss HIV Cohort Study (SHCS); Swiss Mother & Child HIV Cohort Study (MoCHiV).

HIV Med. 2012 Jan;13(1):54-61. doi: 10.1111/j.1468-1293.2011.00936.x. Epub 2011 Jul 3.

Supplemental Content

Support Center